CN Stock MarketDetailed Quotes

300122 Chongqing Zhifei Biological Products

Watchlist
  • 29.34
  • -0.30-1.01%
Market Closed Nov 6 15:00 CST
70.23BMarket Cap19.03P/E (TTM)

Chongqing Zhifei Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-41.98%22.79B
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
Operating revenue
-41.98%22.79B
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
Other operating revenue
----
4,427.67%115.66M
----
5.86%4.08M
----
18.55%2.55M
----
-83.58%3.85M
----
-84.84%2.15M
Total operating cost
-36.80%19.69B
-20.24%15.28B
8.45%9.32B
48.35%43.09B
47.80%31.15B
38.69%19.16B
32.19%8.6B
57.31%29.05B
78.26%21.07B
107.35%13.82B
Operating cost
-41.14%16.58B
-22.23%13.39B
8.22%8.43B
52.29%38.67B
51.56%28.17B
41.00%17.22B
32.79%7.79B
62.56%25.4B
85.16%18.59B
122.40%12.21B
Operating tax surcharges
-36.33%111.44M
-20.56%88.92M
0.96%50.14M
34.87%238.75M
37.39%175.03M
31.81%111.93M
35.60%49.66M
30.90%177.02M
30.75%127.39M
36.93%84.92M
Operating expense
4.95%1.94B
-5.90%1.12B
10.83%495.13M
24.04%2.77B
25.56%1.84B
24.71%1.19B
23.18%446.75M
21.82%2.24B
19.91%1.47B
22.18%950.67M
Administration expense
12.23%306.96M
10.60%202.93M
38.95%110.95M
5.05%393.03M
-0.85%273.5M
6.87%183.49M
10.80%79.85M
24.63%374.13M
37.30%275.84M
33.03%171.7M
Financial expense
54.26%54.31M
-6.35%20.59M
-69.57%5.96M
242.20%47.22M
379.40%35.21M
217.72%21.99M
178.72%19.6M
-36.77%13.8M
-62.63%7.34M
-82.34%6.92M
-Interest expense (Financial expense)
45.30%83.71M
24.11%49.23M
15.25%24.48M
51.98%81M
37.45%57.61M
41.25%39.66M
138.10%21.24M
-5.07%53.3M
-22.39%41.91M
-43.40%28.08M
-Interest Income (Financial expense)
-22.63%-57.76M
-52.04%-47.18M
-125.95%-29.66M
-47.40%-67.94M
-36.55%-47.1M
-44.64%-31.03M
-7.40%-13.13M
25.01%-46.09M
20.18%-34.49M
-33.32%-21.45M
Research and development
7.25%695.55M
5.60%461.35M
9.41%234.08M
13.38%968.47M
6.76%648.54M
12.68%436.88M
32.98%213.96M
54.56%854.16M
152.77%607.5M
138.26%387.72M
Credit Impairment Loss
-6.56%-605.07M
-25.14%-396.67M
-126.58%-340.79M
16.32%-352.71M
-122.44%-567.84M
-58.63%-316.98M
-11.84%-150.41M
-120.78%-421.51M
-59.90%-255.28M
-78.87%-199.83M
Asset Impairment Loss
77.07%-26.4M
80.88%-12.01M
97.03%-1.03M
-186.58%-311.99M
-264.91%-115.14M
-620.30%-62.79M
-223.84%-34.59M
-17.67%-108.87M
-567.91%-31.55M
-114.80%-8.72M
Other net revenue
-25.73%-615.71M
-25.38%-397.6M
-87.50%-335.67M
1.28%-449.97M
-109.96%-489.7M
-93.03%-317.11M
-161.21%-179.02M
-145.10%-455.79M
-75.71%-233.24M
-56.25%-164.28M
Asset deal income
-99.87%54.24K
-99.78%95.41K
----
618,276.31%41.37M
280,967.56%43.05M
281,852.30%43.19M
--41.78K
-82.90%6.69K
-14.47%15.32K
-14.47%15.32K
Other revenue
-89.54%15.71M
-43.60%10.99M
3.78%6.16M
132.43%173.36M
180.39%150.23M
-55.98%19.48M
-84.40%5.93M
-27.63%74.59M
38.41%53.58M
166.73%44.25M
Operating profit
-67.46%2.48B
-48.08%2.58B
-27.54%1.74B
7.02%9.37B
17.18%7.64B
13.57%4.97B
5.62%2.4B
-27.01%8.76B
-34.01%6.52B
-31.69%4.37B
Add:Non operating Income
138.62%38.09K
218.68%38.09K
83.63%18.52K
-44.80%337.69K
-89.19%15.96K
-91.29%11.95K
681.73%10.09K
230.76%611.76K
73.93%147.64K
191.58%137.18K
Less:Non operating expense
-59.53%6.79M
26.00%6.46M
-36.55%2.92M
-23.18%31.48M
-50.39%16.79M
-75.46%5.12M
-27.15%4.6M
-40.69%40.98M
-30.89%33.84M
-16.76%20.88M
Total profit
-67.48%2.48B
-48.16%2.57B
-27.53%1.73B
7.16%9.34B
17.53%7.62B
13.99%4.96B
5.71%2.39B
-26.93%8.72B
-34.02%6.48B
-31.75%4.35B
Less:Income tax cost
-69.94%327.33M
-51.83%338.38M
-23.38%276.02M
7.92%1.27B
24.37%1.09B
12.55%702.41M
5.89%360.26M
-31.55%1.18B
-38.42%875.41M
-29.69%624.11M
Net profit
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Net profit from continuing operation
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Net profit of parent company owners
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Earning per share
Basic earning per share
-67.01%0.8976
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
Diluted earning per share
-67.01%0.8976
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
Other composite income
Total composite income
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Total composite income of parent company owners
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -41.98%22.79B-25.31%18.26B2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B
Operating revenue -41.98%22.79B-25.31%18.26B2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B
Other operating revenue ----4,427.67%115.66M----5.86%4.08M----18.55%2.55M-----83.58%3.85M-----84.84%2.15M
Total operating cost -36.80%19.69B-20.24%15.28B8.45%9.32B48.35%43.09B47.80%31.15B38.69%19.16B32.19%8.6B57.31%29.05B78.26%21.07B107.35%13.82B
Operating cost -41.14%16.58B-22.23%13.39B8.22%8.43B52.29%38.67B51.56%28.17B41.00%17.22B32.79%7.79B62.56%25.4B85.16%18.59B122.40%12.21B
Operating tax surcharges -36.33%111.44M-20.56%88.92M0.96%50.14M34.87%238.75M37.39%175.03M31.81%111.93M35.60%49.66M30.90%177.02M30.75%127.39M36.93%84.92M
Operating expense 4.95%1.94B-5.90%1.12B10.83%495.13M24.04%2.77B25.56%1.84B24.71%1.19B23.18%446.75M21.82%2.24B19.91%1.47B22.18%950.67M
Administration expense 12.23%306.96M10.60%202.93M38.95%110.95M5.05%393.03M-0.85%273.5M6.87%183.49M10.80%79.85M24.63%374.13M37.30%275.84M33.03%171.7M
Financial expense 54.26%54.31M-6.35%20.59M-69.57%5.96M242.20%47.22M379.40%35.21M217.72%21.99M178.72%19.6M-36.77%13.8M-62.63%7.34M-82.34%6.92M
-Interest expense (Financial expense) 45.30%83.71M24.11%49.23M15.25%24.48M51.98%81M37.45%57.61M41.25%39.66M138.10%21.24M-5.07%53.3M-22.39%41.91M-43.40%28.08M
-Interest Income (Financial expense) -22.63%-57.76M-52.04%-47.18M-125.95%-29.66M-47.40%-67.94M-36.55%-47.1M-44.64%-31.03M-7.40%-13.13M25.01%-46.09M20.18%-34.49M-33.32%-21.45M
Research and development 7.25%695.55M5.60%461.35M9.41%234.08M13.38%968.47M6.76%648.54M12.68%436.88M32.98%213.96M54.56%854.16M152.77%607.5M138.26%387.72M
Credit Impairment Loss -6.56%-605.07M-25.14%-396.67M-126.58%-340.79M16.32%-352.71M-122.44%-567.84M-58.63%-316.98M-11.84%-150.41M-120.78%-421.51M-59.90%-255.28M-78.87%-199.83M
Asset Impairment Loss 77.07%-26.4M80.88%-12.01M97.03%-1.03M-186.58%-311.99M-264.91%-115.14M-620.30%-62.79M-223.84%-34.59M-17.67%-108.87M-567.91%-31.55M-114.80%-8.72M
Other net revenue -25.73%-615.71M-25.38%-397.6M-87.50%-335.67M1.28%-449.97M-109.96%-489.7M-93.03%-317.11M-161.21%-179.02M-145.10%-455.79M-75.71%-233.24M-56.25%-164.28M
Asset deal income -99.87%54.24K-99.78%95.41K----618,276.31%41.37M280,967.56%43.05M281,852.30%43.19M--41.78K-82.90%6.69K-14.47%15.32K-14.47%15.32K
Other revenue -89.54%15.71M-43.60%10.99M3.78%6.16M132.43%173.36M180.39%150.23M-55.98%19.48M-84.40%5.93M-27.63%74.59M38.41%53.58M166.73%44.25M
Operating profit -67.46%2.48B-48.08%2.58B-27.54%1.74B7.02%9.37B17.18%7.64B13.57%4.97B5.62%2.4B-27.01%8.76B-34.01%6.52B-31.69%4.37B
Add:Non operating Income 138.62%38.09K218.68%38.09K83.63%18.52K-44.80%337.69K-89.19%15.96K-91.29%11.95K681.73%10.09K230.76%611.76K73.93%147.64K191.58%137.18K
Less:Non operating expense -59.53%6.79M26.00%6.46M-36.55%2.92M-23.18%31.48M-50.39%16.79M-75.46%5.12M-27.15%4.6M-40.69%40.98M-30.89%33.84M-16.76%20.88M
Total profit -67.48%2.48B-48.16%2.57B-27.53%1.73B7.16%9.34B17.53%7.62B13.99%4.96B5.71%2.39B-26.93%8.72B-34.02%6.48B-31.75%4.35B
Less:Income tax cost -69.94%327.33M-51.83%338.38M-23.38%276.02M7.92%1.27B24.37%1.09B12.55%702.41M5.89%360.26M-31.55%1.18B-38.42%875.41M-29.69%624.11M
Net profit -67.07%2.15B-47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B
Net profit from continuing operation -67.07%2.15B-47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B
Net profit of parent company owners -67.07%2.15B-47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B
Earning per share
Basic earning per share -67.01%0.8976-47.48%0.9322-28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538
Diluted earning per share -67.01%0.8976-47.48%0.9322-28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538
Other composite income
Total composite income -67.07%2.15B-47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B
Total composite income of parent company owners -67.07%2.15B-47.55%2.23B-28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data